These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 21747684)
21. Membranous expressions of Lewis y and CAM-DR-related markers are independent factors of chemotherapy resistance and poor prognosis in epithelial ovarian cancer. Zhu LC; Gao J; Hu ZH; Schwab CL; Zhuang HY; Tan MZ; Yan LM; Liu JJ; Zhang DY; Lin B Am J Cancer Res; 2015; 5(2):830-43. PubMed ID: 25973320 [TBL] [Abstract][Full Text] [Related]
22. [Expressions of Ki67, PCNA and mitotic index in ovarian epithelial tumors]. Wang S; Ma XY; Xia Y; Zhang LH Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 41(4):575-80. PubMed ID: 20848772 [TBL] [Abstract][Full Text] [Related]
23. Increase in docetaxel-resistance of ovarian carcinoma-derived RMG-1 cells with enhanced expression of Lewis Y antigen. Zhang F; Liu J; Lin B; Liu Q; Zhao Y; Zhu L; Hao Y; Zhang S; Iwamori M Int J Mol Sci; 2011; 12(11):7323-34. PubMed ID: 22174601 [TBL] [Abstract][Full Text] [Related]
24. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors. Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733 [TBL] [Abstract][Full Text] [Related]
25. Defective expression of Protein 4.1N is correlated to tumor progression, aggressive behaviors and chemotherapy resistance in epithelial ovarian cancer. Xi C; Ren C; Hu A; Lin J; Yao Q; Wang Y; Gao Z; An X; Liu C Gynecol Oncol; 2013 Dec; 131(3):764-71. PubMed ID: 23994105 [TBL] [Abstract][Full Text] [Related]
26. [Expressions of osteopontin and B7-H4 in epithelial ovarian neoplasm and their significance]. Zhang LL; Shao SL; Wu Y Chin J Cancer; 2010 Jan; 29(1):25-9. PubMed ID: 20038306 [TBL] [Abstract][Full Text] [Related]
27. Expression and subcellular localization of maspin in human ovarian epithelial neoplasms: correlation with clinicopathologic features. Abd El-Wahed MM J Egypt Natl Canc Inst; 2005 Sep; 17(3):173-83. PubMed ID: 16799655 [TBL] [Abstract][Full Text] [Related]
28. Crosstalk between integrin αvβ3 and ERα contributes to thyroid hormone-induced proliferation of ovarian cancer cells. Hsieh MT; Wang LM; Changou CA; Chin YT; Yang YSH; Lai HY; Lee SY; Yang YN; Whang-Peng J; Liu LF; Lin HY; Mousa SA; Davis PJ Oncotarget; 2017 Apr; 8(15):24237-24249. PubMed ID: 27458161 [TBL] [Abstract][Full Text] [Related]
29. The thyroid hormone-αvβ3 integrin axis in ovarian cancer: regulation of gene transcription and MAPK-dependent proliferation. Shinderman-Maman E; Cohen K; Weingarten C; Nabriski D; Twito O; Baraf L; Hercbergs A; Davis PJ; Werner H; Ellis M; Ashur-Fabian O Oncogene; 2016 Apr; 35(15):1977-87. PubMed ID: 26165836 [TBL] [Abstract][Full Text] [Related]
30. Lewis y antigen promotes the proliferation of ovarian carcinoma-derived RMG-I cells through the PI3K/Akt signaling pathway. Liu J; Lin B; Hao Y; Qi Y; Zhu L; Li F; Liu D; Cong J; Zhang S; Iwamori M J Exp Clin Cancer Res; 2009 Dec; 28(1):154. PubMed ID: 20003467 [TBL] [Abstract][Full Text] [Related]
31. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma]. Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967 [No Abstract] [Full Text] [Related]
32. Overexpression of Lewis(y) antigen protects ovarian cancer RMG-1 cells from carboplatin-induced apoptosis by the upregulation of Topo-I and Topo-II β. Wang C; Yan L; Wang Y; Lin B; Liu S; Li Q; Gao L; Zhang S; Iwamori M Anat Rec (Hoboken); 2011 Jun; 294(6):961-9. PubMed ID: 21542140 [TBL] [Abstract][Full Text] [Related]
33. Human Epididymis Protein 4 and Lewis y Enhance Chemotherapeutic Resistance in Epithelial Ovarian Cancer Through the p38 MAPK Pathway. Gao J; Zhu L; Zhuang H; Lin B Adv Ther; 2022 Jan; 39(1):360-378. PubMed ID: 34739698 [TBL] [Abstract][Full Text] [Related]
34. Alphav integrin expression is a novel marker of poor prognosis in advanced-stage ovarian carcinoma. Goldberg I; Davidson B; Reich R; Gotlieb WH; Ben-Baruch G; Bryne M; Berner A; Nesland JM; Kopolovic J Clin Cancer Res; 2001 Dec; 7(12):4073-9. PubMed ID: 11751504 [TBL] [Abstract][Full Text] [Related]
35. Expression of Sox2 in human ovarian epithelial carcinoma. Ye F; Li Y; Hu Y; Zhou C; Hu Y; Chen H J Cancer Res Clin Oncol; 2011 Jan; 137(1):131-7. PubMed ID: 20349085 [TBL] [Abstract][Full Text] [Related]
37. Overexpression of alpha(v)beta6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade. Ahmed N; Pansino F; Clyde R; Murthi P; Quinn MA; Rice GE; Agrez MV; Mok S; Baker MS Carcinogenesis; 2002 Feb; 23(2):237-44. PubMed ID: 11872628 [TBL] [Abstract][Full Text] [Related]
38. Expression of VEGF-D in epithelial ovarian cancer and its relationship to lymphatic metastasis. He L; He J; Zhao X Asia Pac J Clin Oncol; 2016 Mar; 12(1):e161-6. PubMed ID: 23915006 [TBL] [Abstract][Full Text] [Related]
39. Lewis (y) antigen overexpression increases the expression of MMP-2 and MMP-9 and invasion of human ovarian cancer cells. Yan L; Lin B; Gao L; Gao S; Liu C; Wang C; Wang Y; Zhang S; Iwamori M Int J Mol Sci; 2010 Nov; 11(11):4441-52. PubMed ID: 21151448 [TBL] [Abstract][Full Text] [Related]
40. Transmigration of human ovarian adenocarcinoma cells through endothelial extracellular matrix involves alphav integrins and the participation of MMP2. Leroy-Dudal J; Demeilliers C; Gallet O; Pauthe E; Dutoit S; Agniel R; Gauduchon P; Carreiras F Int J Cancer; 2005 Apr; 114(4):531-43. PubMed ID: 15609323 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]